Details
Stereochemistry | ACHIRAL |
Molecular Formula | C23H23N5O2 |
Molecular Weight | 401.461 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCN(CC1=CC=CC=C1)C(=O)CN2C(=O)N(C)C3=CN=C(N=C23)C4=CC=CC=C4
InChI
InChIKey=NBMBIEOUVBHEBM-UHFFFAOYSA-N
InChI=1S/C23H23N5O2/c1-3-27(15-17-10-6-4-7-11-17)20(29)16-28-22-19(26(2)23(28)30)14-24-21(25-22)18-12-8-5-9-13-18/h4-14H,3,15-16H2,1-2H3
Molecular Formula | C23H23N5O2 |
Molecular Weight | 401.461 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
DescriptionSources: https://www.ecnp.eu/~/media/Files/ecnp/Projects%20and%20initiatives/Medicines%20Chest/XBD173.pdfCurator's Comment: description was created based on several sources, including:
http://adisinsight.springer.com/drugs/800013611
https://en.wikipedia.org/wiki/Emapunil
Sources: https://www.ecnp.eu/~/media/Files/ecnp/Projects%20and%20initiatives/Medicines%20Chest/XBD173.pdf
Curator's Comment: description was created based on several sources, including:
http://adisinsight.springer.com/drugs/800013611
https://en.wikipedia.org/wiki/Emapunil
Emapunil acts as a selective agonist at the peripheral benzodiazepine receptor (TSPO). At the cellular level, the selective TSPO ligand XBD173 potentiated the amplitude and duration of GABA-mediated inhibitory postsynaptic currents in mouse medial prefrontal cortical neurons, which was prevented by finasteride. In animal and human trials, XBD173 produced rapid anxiolytic and anti-panic effects probably via newly synthesized neurosteroids, without producing sedation or withdrawal symptoms, and may represent a promising target for the development of fast-acting anxiolytics with a more favourable side-effect profile than benzodiazepines.
Originator
Approval Year
Targets
Primary Target | Pharmacology | Condition | Potency |
---|---|---|---|
Target ID: CHEMBL5742 Sources: https://www.ncbi.nlm.nih.gov/pubmed/15249420 |
0.297 nM [Ki] |
Conditions
Condition | Modality | Targets | Highest Phase | Product |
---|---|---|---|---|
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
|||
Primary | Unknown Approved UseUnknown |
PubMed
Title | Date | PubMed |
---|---|---|
[18F]FEAC and [18F]FEDAC: Two novel positron emission tomography ligands for peripheral-type benzodiazepine receptor in the brain. | 2009 Mar 15 |
|
Synthesis and structure-activity relationship studies in translocator protein ligands based on a pyrazolo[3,4-b]quinoline scaffold. | 2011 Oct 27 |
Patents
Sample Use Guides
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/24397957
50uM XBD173 treatment of murine and human microglial cells promoted the formation of filopodia and increased their phagocytic capacity to ingest latex beads or photoreceptor debris. Finally, treatment with XBD173 (20 uM)reversed the amoeboid alerted phenotype of microglial cells in explanted organotypic mouse retinal cultures after challenge with LPS.
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 16:20:40 GMT 2023
by
admin
on
Fri Dec 15 16:20:40 GMT 2023
|
Record UNII |
OG837L732J
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Code | English | ||
|
Code | English | ||
|
Common Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C28197
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
||
|
NCI_THESAURUS |
C29756
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C82906
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
PRIMARY | |||
|
OG837L732J
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
PRIMARY | |||
|
CHEMBL513922
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
PRIMARY | |||
|
6433109
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
PRIMARY | |||
|
DTXSID40177220
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
PRIMARY | |||
|
DB12666
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
PRIMARY | |||
|
226954-04-7
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
PRIMARY | |||
|
100000174972
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
PRIMARY | |||
|
8432
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
PRIMARY | |||
|
EMAPUNIL
Created by
admin on Fri Dec 15 16:20:40 GMT 2023 , Edited by admin on Fri Dec 15 16:20:40 GMT 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TARGET->LIGAND |
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |
|